Replies to post #400165 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Dr. Duffy commented, "My years at Merck, from inception of the Keytruda programs, have been exciting and invaluable. As I look forward now to the next wave of advances in immune therapies for cancer, I am excited about the potential of NW Bio's DCVax technologies to deliver new breakthroughs for patients. I hope to build on my experience in immuno-oncology and my network of relationships in the field to help NW Bio achieve this potential."

Duffy said he was helping NWBO to achieve its potential. In my view that is not just and only browsing around and doing DD on NWBO but also to actually at that moment to help NWBO move forward. As it so happens that at that moment most needed was a required independ third party that could help with the SAP. Outside consultants could not do that.

So I do believe that was one of his jobs at NWBO

But we agree to disagree